Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
depressive symptoms
Pear Therapeutics' latest study will explore digital treatment for MS patients with depressive symptoms
By
Dave Muoio
|
02:13 pm |
May 06, 2019
Development of the Pear-006 digital therapeutic is a joint collaboration with Novartis.